Significant Ownership of Julian C. Baker

Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Julian C. Baker.

Notify me when Julian C. Baker files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Julian C. Baker

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACAD ACADIA Pharmaceuticals Inc. Common Stock, $0.0001 par value per share 25% $1,162,886,859 43,294,373 Julian C. Baker 24 Feb 2026

Schedules 13D/G Reported by Julian C. Baker:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.